Myrtenol Inhibits Biofilm Formation and Virulence in the Drug-Resistant Acinetobacter baumannii: Insights into the Molecular Mechanisms

References

• Chatterjee S, Mondal A, Mitra S, Basu S. Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles. J Antimicrob Chemother. 2017;72(8):2201–2207. doi:10.1093/jac/dkx131
   PubMed Web of Science ®Google Scholar
• Leão AC, Menezes PR, Oliveira MS, Levin AS. Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis. BMC Infect Dis. 2016;16:386. doi:10.1186/s12879-016-1695-8
   Web of Science ®Google Scholar
• Nowak P, Paluchowska P. Acinetobacter baumannii: biology and drug resistance - role of carbapenemases. Folia Histochem Cytobiol. 2016;54(2):61–74. doi:10.5603/FHC.a2016.0009
   Web of Science ®Google Scholar
• Jaidane N, Naas T, Oueslati S, et al. Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia. Int J Antimicrob Agents. 2018;52(6):916–921. doi:10.1016/j.ijantimicag.2018.05.017
   Web of Science ®Google Scholar
• Pritsch M, Zeynudin A, Messerer M, et al. First report on bla NDM-1-producing Acinetobacter baumannii in three clinical isolates from Ethiopia. BMC Infect Dis. 2017;17(1):180. doi:10.1186/s12879-017-2289-9
   Web of Science ®Google Scholar
• Agoba EE, Govinden U, Peer AKC, Osei Sekyere J, Essack SY. ISAba1 regulated OXA-23 carbapenem resistance in Acinetobacter baumannii strains in Durban, South Africa. Microb Drug Resist. 2018;24(9):1289–1295. doi:10.1089/mdr.2017.0172
   Web of Science ®Google Scholar
• Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int. 2014;2014:1–12. doi:10.1155/2014/249856
   Web of Science ®Google Scholar
• Aliramezani A, Soleimani M, Fard RMN, Nojoomi F. Virulence determinants and biofilm formation of Acinetobacter baumannii isolated from hospitalized patients. Germs. 2019;9(3):148–153. doi:10.18683/germs.2019.1171
   PubMedGoogle Scholar
• Villacís JE, Bovera M, Romero-Alvarez D, et al. NDM-1 carbapenemase in Acinetobacter baumannii sequence type 32 in Ecuador. N Microbes New Infect. 2019;29:100526. doi:10.1016/j.nmni.2019.100526
   PubMedGoogle Scholar
• Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist. 2018;15(11):2277–2299. doi:10.2147/IDR.S169894
   Web of Science ®Google Scholar
• Selvaraj A, Valliammai A, Sivasankar C, Suba M, Sakthivel G, Pandian SK. Antibiofilm and antivirulence efficacy of myrtenol enhances the antibiotic susceptibility of Acinetobacter baumannii. Sci Rep. 2020;10(1):21975. doi:10.1038/s41598-020-79128-x
   PubMed Web of Science ®Google Scholar
• Selvaraj A, Jayasree T, Valliammai A, Pandian SK. Myrtenol attenuates MRSA biofilm and virulence by suppressing sarA expression dynamism. Front Microbiol. 2019;4(10):2027. doi:10.3389/fmicb.2019.02027
   Web of Science ®Google Scholar
• Figueiredo AMS, Ferreira FA, Beltrame CO, Côrtes MF. The role of biofilms in persistent infections and factors involved in ica-independent biofilm development and gene regulation in Staphylococcus aureus. Crit Rev Microbiol. 2017;43(5):602–620. doi:10.1080/1040841X.2017.1282941
   PubMed Web of Science ®Google Scholar
• Jayathilaka EH, Rajapaksha DC, Nikapitiya C, De Zoysa M, Whang I. Antimicrobial and anti-biofilm peptide octominin for controlling multidrug-resistant Acinetobacter baumannii. Int J Mol Sci. 2021;22(10):5353. doi:10.3390/ijms22105353
   Web of Science ®Google Scholar
• Kim HR, Shin DS, Jang HI, Eom YB. Anti-biofilm and anti-virulence effects of zerumbone against Acinetobacter baumannii. Microbiology. 2020;166(8):717–726. doi:10.1099/mic.0.000930
   Web of Science ®Google Scholar
• Cordeiro L, Figueiredo P, Souza H, et al. Antibacterial and antibiofilm activity of myrtenol against Staphylococcus aureus. Pharmaceuticals. 2020;13(6):133. doi:10.3390/ph13060133
   Web of Science ®Google Scholar
• Guo HN, Chen Z, Xiang J. [Influence of abaR gene knockout on growth metabolism and biofilm formation of Acinetobacter baumannii]. Zhonghua Shao Shang Za Zhi. 2020;36(1):32–36. Chinese. doi:10.3760/cma.j.issn.1009-2587.2020.01.006
   Google Scholar
• Ramezanalizadeh F, Owlia P, Rasooli I. Type I pili, CsuA/B and FimA induce a protective immune response against Acinetobacter baumannii. Vaccine. 2020;38(34):5436–5446. doi:10.1016/j.vaccine.2020.06.052
   PubMed Web of Science ®Google Scholar
• Krasauskas R, Skerniškytė J, Armalytė J, Sužiedėlienė E. The role of Acinetobacter baumannii response regulator BfmR in pellicle formation and competitiveness via contact-dependent inhibition system. BMC Microbiol. 2019;19(1):241. doi:10.1186/s12866-019-1621-5
   PubMed Web of Science ®Google Scholar
• Schweppe DK, Harding C, Chavez JD, et al. Host-microbe protein interactions during bacterial infection. Chem Biol. 2015;22(11):1521–1530. doi:10.1016/j.chembiol.2015.09.015
   Google Scholar
• Yang CH, Su PW, Moi SH, Chuang LY. Biofilm formation in Acinetobacter baumannii: genotype-phenotype correlation. Molecules. 2019;24(10):1849. doi:10.3390/molecules24101849
   PubMed Web of Science ®Google Scholar
• Nie D, Hu Y, Chen Z, et al. Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection. J Biomed Sci. 2020;27(1):26. doi:10.1186/s12929-020-0617-7
   PubMed Web of Science ®Google Scholar
• Clemmer KM, Bonomo RA, Rather PN. Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology. 2011;157(Pt 9):2534–2544. doi:10.1099/mic.0.049791-0
   PubMed Web of Science ®Google Scholar